The results showed that the proliferation and migration of pancreatic cancer cells were significantly inhibited after adding the LIF inhibitor, and the inhibitory effect was also significantly enhanced as the inhibitor concentration increased (Figure 7C–E). Here, LIF is linked to familial pancreatic carcinoma.